Literature DB >> 6949674

N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.

A T Shulgin, M F Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6949674

Source DB:  PubMed          Journal:  Commun Psychopharmacol        ISSN： 0145-5699


× No keyword cloud information.
  14 in total

1.  The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.

Authors:  Theresa M Carbonaro; Amy J Eshleman; Michael J Forster; Kejun Cheng; Kenner C Rice; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

2.  Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.

Authors:  Michael T Williams; Nicole R Herring; Tori L Schaefer; Matthew R Skelton; Nicholas G Campbell; Jack W Lipton; Anne E McCrea; Charles V Vorhees
Journal:  Neuropsychopharmacology       Date:  2006-10-18       Impact factor: 7.853

3.  Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Authors:  Bruce E Blough; Antonio Landavazo; Ann M Decker; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

4.  Discriminative stimulus effects of N,N-diisopropyltryptamine.

Authors:  Theresa M Carbonaro; Michael J Forster; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2012-10-16       Impact factor: 4.530

5.  Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter.

Authors:  Nicholas V Cozzi; Anupama Gopalakrishnan; Lyndsey L Anderson; Joel T Feih; Alexander T Shulgin; Paul F Daley; Arnold E Ruoho
Journal:  J Neural Transm (Vienna)       Date:  2009-09-12       Impact factor: 3.575

6.  Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.

Authors:  Devon L Graham; Nicole R Herring; Tori L Schaefer; Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicol Teratol       Date:  2009-09-06       Impact factor: 3.763

7.  Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.

Authors:  Matthew R Skelton; Tori L Schaefer; Nicole R Herring; Curtis E Grace; Charles V Vorhees; Michael T Williams
Journal:  Psychopharmacology (Berl)       Date:  2009-02-06       Impact factor: 4.530

8.  Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; Jason Wallach; Simon D Brandt
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.273

Review 9.  Recreational use, analysis and toxicity of tryptamines.

Authors:  Roberta Tittarelli; Giulio Mannocchi; Flaminia Pantano; Francesco Saverio Romolo
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

10.  Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.

Authors:  Karolina Noworyta-Sokołowska; Katarzyna Kamińska; Grzegorz Kreiner; Zofia Rogóż; Krystyna Gołembiowska
Journal:  Neurotox Res       Date:  2016-07-26       Impact factor: 3.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.